(Q38019012)

27 August 2017

Patent-related survey on new monoamine oxidase inhibitors and their therapeutic potential (English)

1 reference

27 August 2017

1

1 reference

27 August 2017

2

Daniela Secci

1 reference

27 August 2017

Adriana Bolasco

3

1 reference

27 August 2017

Paola Chimenti

series ordinal

4

1 reference

27 August 2017

Melissa D'Ascenzio

series ordinal

5

1 reference

27 August 2017

language of work or name

English

0 references

publication date

18 June 2012

1 reference

Expert Opinion on Therapeutic Patents

27 August 2017

1 reference

27 August 2017

22

1 reference

27 August 2017

7

1 reference

27 August 2017

759-801

1 reference

Molecular and mechanistic properties of the membrane-bound mitochondrial monoamine oxidases

27 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

Transcriptional regulation and multiple functions of MAO genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

MAO inhibitors: risks, benefits, and lore

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

The therapeutic potential of monoamine oxidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

Monoamine oxidase inactivation: from pathophysiology to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

MAO-B elevation in mouse brain astrocytes results in Parkinson's pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

Focusing on new monoamine oxidase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

Structure of human monoamine oxidase A at 2.2-A resolution: The control of opening the entry for substrates/inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

Molecular Insights into Human Monoamine Oxidase B Inhibition by the Glitazone Antidiabetes Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

Inhibition of monoamine oxidase by indole and benzofuran derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

Synthesis, stereochemical separation, and biological evaluation of selective inhibitors of human MAO-B: 1-(4-arylthiazol-2-yl)-2-(3-methylcyclohexylidene)hydrazines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

Investigations on the 2-thiazolylhydrazyne scaffold: synthesis and molecular modeling of selective human monoamine oxidase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

Synthesis, semipreparative HPLC separation, biological evaluation, and 3D-QSAR of hydrazothiazole derivatives as human monoamine oxidase B inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

Synthesis, stereochemical identification, and selective inhibitory activity against human monoamine oxidase-B of 2-methylcyclohexylidene-(4-arylthiazol-2-yl)hydrazones

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

Structural insights into monoamine oxidase inhibitory potency and selectivity of 7-substituted coumarins from ligand- and target-based approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

Lipophilicity plays a major role in modulating the inhibition of monoamine oxidase B by 7-substituted coumarins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

The state of the art of pyrazole derivatives as monoamine oxidase inhibitors and antidepressant/anticonvulsant agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

Potentiation of Ligand Binding through Cooperative Effects in Monoamine Oxidase B

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

Synthesis, molecular modeling, and selective inhibitory activity against human monoamine oxidases of 3-carboxamido-7-substituted coumarins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

Synthesis and selective human monoamine oxidase inhibition of 3-carbonyl, 3-acyl, and 3-carboxyhydrazido coumarin derivatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

Inhibition of monoamine oxidases by coumarin-3-acyl derivatives: biological activity and computational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

A QSAR model for in silico screening of MAO-A inhibitors. Prediction, synthesis, and biological assay of novel coumarins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

A new series of 3-phenylcoumarins as potent and selective MAO-B inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

New halogenated 3-phenylcoumarins as potent and selective MAO-B inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

8-Substituted 3-arylcoumarins as potent and selective MAO-B inhibitors: synthesis, pharmacological evaluation, and docking studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

Inhibitory effects of cis- and trans-resveratrol on noradrenaline and 5-hydroxytryptamine uptake and on monoamine oxidase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

Synthesis and study of a series of 3-arylcoumarins as potent and selective monoamine oxidase B inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

Chromone-2- and -3-carboxylic acids inhibit differently monoamine oxidases A and B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

Chromone, a privileged scaffold for the development of monoamine oxidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

Chromone 3-phenylcarboxamides as potent and selective MAO-B inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

Different stereoselective inhibition of monoamine oxidase-B by the R- and S-enantiomers of MD 780236

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

New carbon-linked azole oxazolidinones with improved potency and pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

Interactions of Monoamine Oxidases with the Antiepileptic Drug Zonisamide: Specificity of Inhibition and Structure of the Human Monoamine Oxidase B Complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

Facile synthesis of substituted trans-2-arylcyclopropylamine inhibitors of the human histone demethylase LSD1 and monoamine oxidases A and B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

Propargylamine containing compounds as modulators of proteolytic cleavage of amyloid-beta protein precursor: involvement of MAPK and PKC activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

Recent advances in the development of hybrid molecules/designed multiple compounds with antiamnesic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

A new and rapid colorimetric determination of acetylcholinesterase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

Alzheimer's disease: from pathogenesis to disease-modifying approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

The role of iron as a mediator of oxidative stress in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

M30, a brain permeable multitarget neurorestorative drug in post nigrostriatal dopamine neuron lesion of parkinsonism animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

Novel molecular targets of the neuroprotective/neurorescue multimodal iron chelating drug M30 in the mouse brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

Monoamine reuptake inhibition and mood-enhancing potential of a specified oregano extract

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

The selegiline transdermal system in major depressive disorder: a systematic review of safety and tolerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

Reversible inhibitors of monoamine oxidase-A (RIMAs): robust, reversible inhibition of human brain MAO-A by CX157.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

Controversies in neurology: why monoamine oxidase B inhibitors could be a good choice for the initial treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

New considerations in the medical management of early Parkinson's disease: impact of recent clinical trials on treatment strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

Modelling the roles of MAO and SSAO in glucose transport.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

A systematic review on the effectiveness of treatment with antidepressants in fibromyalgia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

Targeting monoamine oxidase A in advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

Increase of monoamine oxidase-B activity in the brain of scrapie-infected hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

Monoamine oxidase and tobacco dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

Monoamine oxidases (MAO) in the pathogenesis of heart failure and ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

Insomnia, platelet serotonin and platelet monoamine oxidase in chronic alcoholism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

Impact of species-dependent differences on screening, design, and development of MAO B inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

The novel multifunctional, iron-chelating drugs M30 and HLA20 protect pancreatic beta-cell lines from oxidative stress damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

Towards the Discovery of a Novel Class of Monoamine Oxidase Inhibitors: Structure-Property-Activity and Docking Studies on Chromone Amides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.698613

10.1517/13543776.2012.698613

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference